Bad Blood: Secrets and Lies in a Silicon Valley Startup
- ΠΠ΅ΡΠ΅ΠΏΠ»ΡΡ ΠΡΠ³ΠΊΠΈΠΉ
- ΠΠΎΠ»-Π²ΠΎ ΡΡΡ. 339
- ΠΠ΅Ρ 270 Π³
- ΠΠΎΠ΄ ΠΈΠ·Π΄Π°Π½ΠΈΡ 2018
ΠΡΠ·ΡΠ²Ρ
ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΈ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
- ΠΠ΅ΡΠ΅ΠΏΠ»ΡΡ ΠΡΠ³ΠΊΠΈΠΉ
- ΠΠΎΠ»-Π²ΠΎ ΡΡΡ. 339
- ΠΠ΅Ρ 270 Π³
- ΠΠΎΠ΄ ΠΈΠ·Π΄Π°Π½ΠΈΡ 2018
- ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ
- Π Π°Π·ΠΌΠ΅ΡΡ Π² ΡΠΌ 2x13x19.7
- ID ΡΠΎΠ²Π°ΡΠ° 2847514
- ISBN 978-1-50-986808-7, 978-1-5098-6808-7